Premier Health of America Inc.

Premier Health of America Inc. is a specialized Canadian enterprise dedicated to providing comprehensive healthcare services. The company offers both staffing solutions and outsourced operational support to meet diverse healthcare demands across the nation. Its service portfolio extends to health consulting, professional nursing care, and general healthcare provision, particularly for remote communities. Additionally, it manages medical transport services and operates Code Bleu, an agency specializing in the recruitment and placement of various healthcare professionals, including nurses, caregivers, and dental and other medical support staff. All its services are efficiently delivered and managed via PSweb, the company's proprietary Customer Relationship Management platform. Premier Health caters to a broad spectrum of clients, from government bodies and corporations to individual patients, public and private hospitals, medical clinics, and retirement residences. Founded in 2003, the company's main headquarters are located in Blainville, Canada.

Premier Health of America Inc. trades as PHA.V on TSXV. The company is classified in Healthcare / Medical - Care Facilities and reports in CAD.

The current profile places the business in Medical - Care Facilities. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $101.97M of revenue and -$15.44M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Premier Health of America Inc. can be compared against peers such as Captor Capital Corp., Copland Road Capital Corporation, Entheon Biomedical Corp., Universal Ibogaine Inc., Doseology Sciences Inc., Ovation Science Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $1.11M, beta of -0.04, and return on equity of +137.0%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

PHA.V currently shows total debt of $45.34M and beta of -0.04. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.premierhealthgroup.ca

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.